Most individuals with RTT who have a clinical diagnosis do have an MECP2 pathogenic variant, and evidence from the natural history study has shown that 98% of individuals with a clinical diagnosis of classic RTT and 86% with a clinical diagnosis of atypical RTT had a pathogenic MECP2 variant [84]. Here, MECP2 is linked to Rett syndrome.